Until recently, DNMT proteins had not been found mutated in cancer[3], but DNMT3A, and later DNMT1 and DNMT3B, were reported as altered in patients with myelodysplastic syndromes and in acute monocytic leukemia, where their mutation status also predicted prognosis[4,5]. This evidence concerns the gene DNMT1 and cancer.